Shareholders' Equity - Additional Information (Detail) (USD $)	3 Months Ended	12 Months Ended							12 Months Ended			12 Months Ended			12 Months Ended								12 Months Ended							12 Months Ended
	Mar. 28, 2010	Dec. 30, 2012 hour	Dec. 25, 2011	Dec. 26, 2010	Dec. 30, 2012 Maximum	Dec. 30, 2012 Minimum	Dec. 30, 2012 First 5 Percent of Employee Contributions	Jul. 31, 2008 First 6 Percent of Employee Contributions	Dec. 30, 2012 Stock options and other	Dec. 30, 2012 Stock options and other Employee	May 04, 2010 Stock options and other Employee	Dec. 30, 2012 Stock options and other Employee Options Issued from 1996 through November 2004	Dec. 30, 2012 Stock options and other Employee Options Issued in December 2004 and Thereafter	Dec. 30, 2012 Stock options and other Employee Minimum	Dec. 30, 2012 Stock options and other Director	Dec. 25, 2011 Stock options and other Director	Dec. 26, 2010 Stock options and other Director	Dec. 30, 2012 Stock options and other Director Retainer Fees	Dec. 30, 2012 Stock options and other Director Long-Term Awards	Dec. 30, 2012 Performance Based Awards Stock Based Award	Dec. 30, 2012 Restricted Stock Units (RSUs) Employee	Dec. 30, 2012 Restricted Stock Employee	Dec. 30, 2012 Restricted Stock Director	Dec. 25, 2011 Restricted Stock Director	Dec. 26, 2010 Restricted Stock Director	Dec. 30, 2012 Restricted Stock Director Retainer Fees	Dec. 30, 2012 Restricted Stock Director Long-Term Awards	Dec. 30, 2012 Performance Shares	Dec. 30, 2012 Performance Units and Cash-Based Awards	Dec. 30, 2012 Restricted Stock and Restricted Stock Units	Dec. 25, 2011 Restricted Stock and Restricted Stock Units	Dec. 26, 2010 Restricted Stock and Restricted Stock Units
Stockholders Equity Note [Line Items]
Stock options outstanding excluded from calculation of diluted earnings per share		6,500,000	18,300,000	19,600,000
Shares approved to be repurchased under share repurchase program, amount		$ 300,000,000
Shares repurchased under share repurchase program, shares		10,300,000	4,900,000	0
Remaining authorized repurchase amount		150,000,000
Cost of common shares repurchased		153,948,000	53,037,000	0
Shares reserved for issuance											60,000,000
Award vesting period																		1 year	4 years	3 years						1 year	3 years
Number of units ultimately paid for performance share awards of target (as a percent)					2	0
Number of shares of common stock received for each RSU granted																					1
Maximum number of awards that can be granted to any participant in any fiscal year										1,000,000											500,000	500,000						500,000
Options to purchase common stock, purchase price as percentage of fair market value														100.00%
Options exercise period												10 years	8 years
Options exercisable percentage per year										25.00%
Stock options awarded		109,699	1,333,597	3,451,481											74,611	61,897	72,681
Shares awarded																							31,929	27,523	21,062			1,109,873		1,937,512	175,023	1,934,351
Maximum number of awards that can be granted to any participant in any fiscal year																													10,000,000
Stock options exercised		2,716,637	496,749	332,060
Cash received from exercise of stock options	2,000,000	24,505,000	2,352,000	1,978,000
Intrinsic value of options exercised	3,100,000	22,400,000	3,900,000
Tax benefit realized from option exercises	1,200,000	9,200,000	1,300,000
Unrecognized compensation cost related to non-vested share-based compensation									4,400,000																			5,900,000		28,000,000
Unrecognized compensation cost related to non-vested share-based compensation for options, recognition period (in years)									1 year 8 months 12 days																			2 years		2 years 4 months 24 days
Minimum number of employee working hours required to be eligible to participate in the 401(k) Savings Plan (in hours)		1,000
401(k) employee maximum matching contribution		50.00%
401(k) employer matching contribution							100.00%	50.00%
Compensation expense related to 401(k) contributions		51,300,000	49,600,000	46,000,000
Accumulated other comprehensive loss, pension, retiree medical and life insurance liabilities		1,120,000,000	996,000,000
Accumulated other comprehensive loss, foreign currency translation gains		$ 418,000,000	$ 400,000,000